Trevor Hawkins’ 25+ year career in healthcare has included business, academic innovation and entrepreneurship. He is a visiting Professor at NYU and serves on several boards focusing on new technology and innovative solutions. Dr. Hawkins was previously Director of the Human Genome Project for the DOE, and held senior executive roles at Siemens Healthcare, Philips, GE Healthcare and Amersham. He was also previously Chairman & CEO of ProGenTech, a privately held company based in Shanghai & San Francisco, and a founder of the Beijing Genome Institute, of which he remains an Honorary Professor and Director. Dr. Hawkins invented SPRI – Solid Phase Reversible Immobilization – the magnetic bead nucleic acid isolation method used as the sample prep method for the Human Genome Project. Dr. Hawkins has published over 50 peer-reviewed articles on automation, genomics, human diseases and the human genome project.